CoChat

CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer

Open access
Bhattarai, Shanta, Mackeyev, Yuri, Venkatesulu, Bhanu P., Krishnan, Sunil, Singh, Pankaj K. · 2021 · Nanoscale

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

CXC chemokine receptor 4 (CXCR4) is overexpressed on most breast cancer cell surfaces including triple negative breast cancer (TNBC) which lacks traditional receptor overexpression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1039/d1nr05385j

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

21 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 26 references

Research works printed but not linked: 2

  1. Mukherjee, 2013, Am. J. Cancer Res., 3, 46
  2. Xu, 2015, Drug Des. Devel. Ther., 9, 4953

Cited by

See all 22

Metadata

Authors
Bhattarai, S., Mackeyev, Y., Venkatesulu, B. P., Krishnan, S., & Singh, P. K.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • Mayo Clinic (US)
  • Henry Ford Hospital (US)
Corresponding author
Singh, Pankaj K.
Venue
Nanoscale
Published
2021
Volume
13
Issue
45
Pages
19056-19065
ISSN
  • 2040-3364 (ISSN-L)
  • 2040-3372
OpenAlex
W3205736542
Cited by
22
References
26
Citations by year
2026: 6 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 3
FWCI
1.79
Type
journal article
Language
en
Open access
Locations
  • Nanoscale (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Cancer Institute (P30 CA16672)
  • National Institutes of Health (P30 CA16672)
Topics
  • Physical Sciences › Physics and Astronomy › Radiation › Radiation Therapy and Dosimetry
  • Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Effects of Radiation Exposure
Keywords
CXCR4, gold nanoparticles, targeted radiotherapy, triple-negative breast cancer, radiosensitization, antibody-conjugated nanoparticles, PEGylated nanoparticles, DNA double-strand breaks, oxidative stress, reactive oxygen species, nanoparticle uptake, tumor regrowth, MDA-MB-231 cells
MeSH terms
Animals, Breast Neoplasms, Female, Gold, Humans, Receptors, CXCR4, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Metal Nanoparticles, Triple Negative Breast Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer. https://app.cochat.ai/papers/10.1039/d1nr05385j
The paper
Bhattarai, S., Mackeyev, Y., Venkatesulu, B. P., Krishnan, S., & Singh, P. K. (2021). CXC chemokine receptor 4 (CXCR4) targeted gold nanoparticles potently enhance radiotherapy outcomes in breast cancer. Nanoscale. https://doi.org/10.1039/d1nr05385j

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.